Highest-scoring questions on the site.
The lot number on the vial matches the certificate, which at least rules out the easy problem. The figures are clear enough; the question is what they mean and what…
Conditions: 12 units · 5 mg/mL. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one mistake here that…
The case in front of me: 98.4% · VendorInvestigate · 97.6% · Medutest. These are treated as interchangeable and I do not think they are. If both are acceptable I…
Setup, so nobody has to ask: aggregation · minus 20 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
What I am working with: Medutest · Shanghai Sigma-Audley. I have read the primary source rather than the summary, which has left me with more questions. I understand…
The case in front of me: 98.8% · liraglutide · FGP. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I…
For reference: liraglutide · 2.5 mg/mL · twelve weeks. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested…
The clinician who ordered the panel was not concerned; I would still like to understand it. Please show the division. I want to check my own against yours. I would…
The case in front of me: ecnoglutide · 2–8 °C. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one.…
I am comparing three suppliers on documentation rather than on price. I would like to know the limits of what can be inferred from this. What I am trying to avoid is…
The case in front of me: TFC · GL Biochem · Ireland. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
Concretely: QST · Changsha · Singapore. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write…
Conditions: FLOW · 2 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which I have…
My records go back to the first dose with dates, so I can reconstruct the timeline exactly. These are treated as interchangeable and I do not think they are. If both…
Conditions: constipation · liraglutide · PIONEER-4. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Concretely: 37 °C · tirzepatide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Is there data…
What I am working with: constipation · ten · semaglutide. Everything I have found on this is either a forum aside or a product page, neither of which I trust. I am…
Setup, so nobody has to ask: early satiety · eight · semaglutide. Everything I have found on this is either a forum aside or a product page, neither of which I trust.…
What I am working with: retatrutide · fourteen days. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
Setup, so nobody has to ask: aggregation · cagrilintide · room temperature. The empirical answer seems settled. The explanation does not. If the honest answer is that…
What I am working with: dulaglutide · 4 °C. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory. What I…
For reference: date of analysis · HJ. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules,…
The specifics, since they change the answer: Changsha · Finland. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I…
Setup, so nobody has to ask: STEP 1 · a GLP-1 receptor agonist. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary…